{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:39:57Z","timestamp":1792147197995,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T00:00:00Z","timestamp":1291334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10620-010-1476-y","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T06:09:31Z","timestamp":1291270171000},"page":"276-278","source":"Crossref","is-referenced-by-count":17,"title":["Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC)"],"prefix":"10.1007","volume":"56","author":[{"given":"Palak Jitendrakumar","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"1476_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693\u2013699.","journal-title":"N Engl J Med"},{"key":"1476_CR2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.510270616","volume":"27","author":"JM Llovet","year":"1998","unstructured":"Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572\u20131577.","journal-title":"Hepatology"},{"key":"1476_CR3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","volume":"111","author":"J Bruix","year":"1996","unstructured":"Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018\u20131022.","journal-title":"Gastroenterology"},{"key":"1476_CR4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/jhep.2001.23561","volume":"33","author":"S Jonas","year":"2001","unstructured":"Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080\u20131086.","journal-title":"Hepatology"},{"key":"1476_CR5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208\u20131236.","journal-title":"Hepatology"},{"key":"1476_CR6","unstructured":"Bruix J, Sherman M. AASLD practice guideline. Management of hepatocellular carcinoma: an update. 2010. http:\/\/www.aasld.org\/practiceguidelines\/Documents\/Bookmarked%20Practice%20Guidelines\/HCCUpdate2010.pdf . Accessed 29 October 2010."},{"key":"1476_CR7","first-page":"417","volume":"130","author":"BH Zhang","year":"2004","unstructured":"Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417\u2013422.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1476_CR8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","volume":"101","author":"FP Sarasin","year":"1996","unstructured":"Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med. 1996;101:422\u2013434.","journal-title":"Am J Med"},{"key":"1476_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1572-0241.2003.07327.x","volume":"98","author":"MR Arguedas","year":"2003","unstructured":"Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost utility analysis. Am J Gastroenterol. 2003;98:679\u2013690.","journal-title":"Am J Gastroenterol"},{"key":"1476_CR10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2004.01963.x","volume":"19","author":"OS Lin","year":"2004","unstructured":"Lin OS, Keeffe EB, Sanders GD, Owens DK. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther. 2004;19:1159\u20131172.","journal-title":"Aliment Pharmacol Ther"},{"key":"1476_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1872-034X.2007.00216.x","volume":"38","author":"M Makuuchi","year":"2008","unstructured":"Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37\u201351.","journal-title":"Hepatol Res"},{"key":"1476_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1572-0241.2002.05557.x","volume":"97","author":"F Trevisani","year":"2002","unstructured":"Trevisani F, De NS, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97:734\u2013744.","journal-title":"Am J Gastroenterol"},{"key":"1476_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-10-3310","volume":"102","author":"E Santagostino","year":"2003","unstructured":"Santagostino E, Colombo M, Rivi M, et al. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood. 2003;102:78\u201382.","journal-title":"Blood"},{"key":"1476_CR14","doi-asserted-by":"crossref","first-page":"403A","DOI":"10.1016\/j.jhep.2006.09.019","volume":"46","author":"DK Kim","year":"2007","unstructured":"Kim DK, Han KH, Ahn SH, et al. Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual survillance (Korean experience). Hepatology. 2007;46:403A.","journal-title":"Hepatology"},{"issue":"1","key":"1476_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","volume":"42","author":"JJ Field","year":"2005","unstructured":"Field JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42(1):53\u201362.","journal-title":"Hepatology"},{"key":"1476_CR16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008;48:863\u2013870.","journal-title":"Hepatology"},{"issue":"5","key":"1476_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel A, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, Kanzler S. Hepatocellular carcinoma in patients with autoimmune hepatitis. World Journal of Gastroenterol. 2009;15(5):578\u2013582.","journal-title":"World Journal of Gastroenterol"},{"key":"1476_CR18","doi-asserted-by":"crossref","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci. doi: 10.1007\/s10620-010-1444-6","DOI":"10.1007\/s10620-010-1444-6"},{"issue":"5","key":"1476_CR19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2893.2004.00521.x","volume":"11","author":"M Anzola","year":"2004","unstructured":"Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat. 2004;11(5):383\u2013393.","journal-title":"J Viral Hepat"},{"issue":"5","key":"1476_CR20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.22793","volume":"49","author":"MM Hassan","year":"2009","unstructured":"Hassan MM, Kaseb A, Li D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009;49(5):1563\u20131570.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1476-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1476-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1476-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T18:51:31Z","timestamp":1559847091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1476-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1476-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}